Joanne Young
Scientific Director Cytoo
Seminars
Wednesday 15th July 2026
Preserving Muscle During Obesity Treatment: Can We Do Better Than Bimagrumab? Insights from the MyoScreen™ Human Muscle Platform
3:00 pm
- MyoScreen™: a translationally relevant in vitro human muscle platform for discovering and profiling muscle-preserving candidates
- Benchmarking against bimagrumab across multiple muscle atrophy models
- Comprehensive profiling of muscle-preserving activities: contractility, glucose uptake, mitochondrial health, lipid handling, calcium flux and AChR clustering
